Request demo

Science Resources: Webinar

This is where you can add text to each archive by editing the category and using the category description field which allows html etc.

Combating antibiotic resistance through ligand- and structure-based virtual screening
We demonstrate how Cresset’s virtual screening technologies can be used to identify inhibitors on an emerging antibacterial therapeutic target...
Active learning FEP using 3D-QSAR for prioritizing bioisosteres in medicinal chemistry
We present an active learning workflow using Free Energy Perturbation to efficiently identify the strongest-binding bioisosteric replacement...
Using the new features in Flare™ V10 to help identify the molecules that matter for your project
The new features in Cresset Flare™ V10 help identify interesting compounds, driving efficiencies that lead to time and cost savings...
A collaborative lead optimization workflow for computational and medicinal chemists
We demonstrate an efficient workflow for medicinal and computational chemists who need to share and effectively triage new ideas...
Webinar: Revolutionizing Drug Discovery with AI
Explore how Cresset AI is revolutionizing the drug discovery process by optimizing workflows, enhancing productivity and empowering decisions...
A Free Energy Perturbation (FEP) study: Identifying ‘new’, active ligands for TYK2
We demonstrate a free energy perturbation study to accurately predict the binding affinity of “new” ligand suggestions with the...
Getting the Most from Flare’s AI Copilots – Tips and Insights
AI-enabled assistants are now integrated into Flare – we demonstrate the Chat Model (doc-aware guidance for GUI features) and Code Model...
Discovery and development of EP652, A METTL3 Inhibitor with efficacy in liquid and Solid Tumour Models
We highlight computational analysis and modeling that facilitated in-silico design; providing a potent, active and tractable METTL3 inhibitor...
Modality Agnostic Drug Discovery Strategies for Data Sparse Targets
This webinar in collaboration with Avammune, focuses on pursuing novel drug discovery targets with sparse or fragmented data...
What’s new in Flare™ V12: significant enhancements to FEP and structure-based methods
Find out what’s new in Flare V12 in our latest webinar
2 / 22

Subscribe & Don't Miss Out

Receive our newsletter to be among the first to hear about product releases, case studies, opinion articles, events and more.
Subscribe

News & Events

BiotechX Europe 1600 x 900px
BiotechX Europe 2026
Messe Basel, Switzerland
October 6, 2026
Cresset are exhibiting at BiotechX Europe in Switzerland in October. Meet the team at booth 339 and explore how you can improve your current drug discovery workflows.
1600 x 900 What’s new in Flare V12 improvements to FEP Webinar
What’s new in Flare™ V12: significant enhancements to FEP and structure-based methods
Online
July 16, 2026
Find out what’s new in Flare™ V12 in our latest webinar with significant enhancements to FEP and structure-based methods
25th EuroQSAR 1600 x 900px
25th EuroQSAR
Perugia, Italy
September 27, 2026
We’re exhibiting at this year’s EuroQSAR. Pass by the stand to speak to the team and learn more about how Cresset computational and AI drug discovery solutions can help you accelerate your projects.
AI in Drug Discovery Xchange - San Francisco 2026 1600 x 900px
AI in Drug Discovery Xchange
San Francisco, USA
September 9, 2026
Cresset is sponsor of the next Ai in Drug Discovery Xchange in San Francisco. Don’t miss the chance to meet the team and attend our round table on lead generation and optimization.
Press Release Scaffold Hopping B
Cresset releases Flare V12 to cut synthesis and testing cycles with faster, more flexible FEP
Cresset releases Flare V12, a new version of its computer-aided drug design (CADD) solution for the discovery, design and optimization of small molecules. Flare V12 is focussed on improving access to Free Energy Perturbation (FEP) in drug discovery.
EFMC Medicinal Chemistry Symposium 1600 x 900px
EFMC-ISMC (International Symposium on Medicinal Chemistry)
Basel
September 6, 2026
Cresset is a sponsor at the upcoming EFMC-ISMC event in Basel. Come and see us at stand 10 to discuss how Cresset’s software solutions can improve your drug discovery workflows.
Publication Spotlight blog post METTL3 Inhibitor 1600 x 900 px
Cresset Discovery accelerates optimization of METTL3 inhibitor
Cresset Discovery has delivered a highly efficient digital workflow combining their molecular modeling expertise with Cresset technology to accelerate discovery, design and optimization of a METTL3 inhibitor.